首页 > 最新文献

Eurasian Journal of Medicine最新文献

英文 中文
The Clinical Impact of the Decipher Genomic Classifier in Prostate Cancer. 破译基因组分类器在前列腺癌中的临床作用。
IF 0.9 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-05-05 DOI: 10.5152/eurasianjmed.2025.25828
Sophia Li, Stephanie A Berg, Mutlay Sayan

The Decipher genomic classifier (GC) is a 22-gene expression test that refines risk stratification and informs treatment decisions in localized prostate cancer. Traditional clinicopathologic factors, including prostate-specific antigen levels and kinetics, Gleason score, histologic variants, and tumor stage, do not fully capture disease heterogeneity, leading to potential overtreatment or undertreatment. The Decipher GC has demonstrated clinical utility across risk groups, helping to distinguish candidates for active surveillance in low-risk prostate cancer, refine the need for androgen deprivation therapy in intermediate-risk disease, and guide treatment intensification in high-risk patients. In the post-radical prostatectomy setting, the GC aids in determining the need for early salvage radiation therapy and hormonal therapy. While retrospective studies support its prognostic value, limitations include heterogeneity in study designs and the lack of established predictive utility for treatment response. Ongoing prospective trials, such as NRG GU-009 and NRG GU-010, aim to validate further the Decipher GC's role in clinical decision-making and treatment personalization.

破译基因组分类器(GC)是一项22个基因表达测试,可细化风险分层,并为局部前列腺癌的治疗决策提供信息。传统的临床病理因素,包括前列腺特异性抗原水平和动力学、Gleason评分、组织学变异和肿瘤分期,不能完全反映疾病的异质性,导致潜在的过度治疗或治疗不足。破译GC已经证明了在危险人群中的临床效用,有助于区分低风险前列腺癌的主动监测候选人,完善中风险疾病的雄激素剥夺治疗需求,并指导高危患者的治疗强化。在根治性前列腺切除术后,GC有助于确定是否需要早期补救性放射治疗和激素治疗。虽然回顾性研究支持其预后价值,但其局限性包括研究设计的异质性和缺乏对治疗反应的既定预测效用。正在进行的前瞻性试验,如NRG GU-009和NRG GU-010,旨在进一步验证破译GC在临床决策和治疗个性化中的作用。
{"title":"The Clinical Impact of the Decipher Genomic Classifier in Prostate Cancer.","authors":"Sophia Li, Stephanie A Berg, Mutlay Sayan","doi":"10.5152/eurasianjmed.2025.25828","DOIUrl":"10.5152/eurasianjmed.2025.25828","url":null,"abstract":"<p><p>The Decipher genomic classifier (GC) is a 22-gene expression test that refines risk stratification and informs treatment decisions in localized prostate cancer. Traditional clinicopathologic factors, including prostate-specific antigen levels and kinetics, Gleason score, histologic variants, and tumor stage, do not fully capture disease heterogeneity, leading to potential overtreatment or undertreatment. The Decipher GC has demonstrated clinical utility across risk groups, helping to distinguish candidates for active surveillance in low-risk prostate cancer, refine the need for androgen deprivation therapy in intermediate-risk disease, and guide treatment intensification in high-risk patients. In the post-radical prostatectomy setting, the GC aids in determining the need for early salvage radiation therapy and hormonal therapy. While retrospective studies support its prognostic value, limitations include heterogeneity in study designs and the lack of established predictive utility for treatment response. Ongoing prospective trials, such as NRG GU-009 and NRG GU-010, aim to validate further the Decipher GC's role in clinical decision-making and treatment personalization.</p>","PeriodicalId":53592,"journal":{"name":"Eurasian Journal of Medicine","volume":"57 2","pages":"1-4"},"PeriodicalIF":0.9,"publicationDate":"2025-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12102616/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144103153","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Threat Emerging in Patients with Hematological Malignancy: Invasive Magnusiomyces capitatus and Magnusiomyces clavatus Infections. 恶性血液病患者的威胁:侵袭性大写Magnusiomyces和锁骨Magnusiomyces感染。
IF 0.9 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-04-30 DOI: 10.5152/eurasianjmed.2025.24565
Rukiye İnan Sarıkaya, Ayşe Albayrak, Fuat Erdem, Muhammet Hamidullah Uyanık, Şeyma Demirelli, Zafer Bıçakçı, Kemalettin Özden

Background: Magnusiomyces capitatus (M. capitatus) and Magnusiomyces clavatus (M. clavatus) are rare cause of fungemia leading to high mortality rates, particularly in neutropenic patients with hematological malignancies. This research set out to explore the clinical characteristics of patients with hematological malignancies with M. capitatus and M. clavatus fungemia. Methods: Eight patients from whom Magnusiomyces spp. were isolated, from among patients hospitalized at the Atatürk University Hospital between October 2017 and November 2022, were enrolled in this retrospective observational study. The 8 patients' medical data were subjected to analysis. Results: Magnusiomyces capitatus emerged as the pathogen in 5 cases and M. clavatus in 3. The patients' median age was 35.5 years. The most common underlying hematological malignancy was acute leukemia. Neutrophil values of 500 cells/mm3 were detected in all patients during Magnusiomyces spp. isolation, with severe neutropenia at less than 100 cells/mm3 in 5. The mean duration of neutropenia prior to Magnusiomyces spp. isolation was 29 days. Breakthrough fungemia developed in 7 patients using echinocandins, fluconazole, and posaconazole. Liposomal amphotericin B and voriconazole were used for initial treatment. The general mortality rate was 37%. All isolates were resistant to echinocandins. Voriconazole possessed the lowest minimum inhibitory concentration value against all isolates. The survival rate was higher among young patients. Mortality was higher among patients followed up in the intensive care unit. Conclusion: Life-threatening Magnusiomyces spp. can spread among patients with long-term neutropenia under treatment for hematological malignancies. Awareness and prompt initiation of treatment can reduce the risk of mortality in invasive infections caused by Magnusiomyces spp.

背景:大写Magnusiomyces capitatus (M. capitatus)和棒状Magnusiomyces clavatus (M. clavatus)是引起真菌血症的罕见原因,导致高死亡率,特别是在中性粒细胞减少的血液系统恶性肿瘤患者中。本研究旨在探讨血液学恶性肿瘤合并头状分枝杆菌和棍状分枝杆菌真菌血症患者的临床特点。方法:从2017年10月至2022年11月在atatatrk大学医院住院的患者中分离出8例Magnusiomyces spp,纳入本回顾性观察研究。对8例患者的医疗资料进行分析。结果:5例出现大写Magnusiomyces capitatus, 3例出现clavatus。患者中位年龄为35.5岁。最常见的潜在血液恶性肿瘤是急性白血病。在Magnusiomyces spp.分离期间,所有患者均检测到中性粒细胞值为500个细胞/mm3,其中5例患者出现严重中性粒细胞减少,低于100个细胞/mm3。Magnusiomyces spp.分离前中性粒细胞减少的平均持续时间为29天。7例患者使用棘白菌素、氟康唑和泊沙康唑后出现突破性真菌血症。初始治疗采用两性霉素B脂质体和伏立康唑。总死亡率为37%。所有分离株均对棘白菌素耐药。伏立康唑对各菌株的最低抑菌浓度值最低。年轻患者的生存率较高。在重症监护病房随访的患者死亡率较高。结论:危及生命的Magnusiomyces可在长期中性粒细胞减少的血液系统恶性肿瘤治疗患者中传播。意识到并及时开始治疗可以降低Magnusiomyces spp引起的侵袭性感染的死亡风险。
{"title":"A Threat Emerging in Patients with Hematological Malignancy: Invasive Magnusiomyces capitatus and Magnusiomyces clavatus Infections.","authors":"Rukiye İnan Sarıkaya, Ayşe Albayrak, Fuat Erdem, Muhammet Hamidullah Uyanık, Şeyma Demirelli, Zafer Bıçakçı, Kemalettin Özden","doi":"10.5152/eurasianjmed.2025.24565","DOIUrl":"10.5152/eurasianjmed.2025.24565","url":null,"abstract":"<p><p>Background: Magnusiomyces capitatus (M. capitatus) and Magnusiomyces clavatus (M. clavatus) are rare cause of fungemia leading to high mortality rates, particularly in neutropenic patients with hematological malignancies. This research set out to explore the clinical characteristics of patients with hematological malignancies with M. capitatus and M. clavatus fungemia. Methods: Eight patients from whom Magnusiomyces spp. were isolated, from among patients hospitalized at the Atatürk University Hospital between October 2017 and November 2022, were enrolled in this retrospective observational study. The 8 patients' medical data were subjected to analysis. Results: Magnusiomyces capitatus emerged as the pathogen in 5 cases and M. clavatus in 3. The patients' median age was 35.5 years. The most common underlying hematological malignancy was acute leukemia. Neutrophil values of 500 cells/mm3 were detected in all patients during Magnusiomyces spp. isolation, with severe neutropenia at less than 100 cells/mm3 in 5. The mean duration of neutropenia prior to Magnusiomyces spp. isolation was 29 days. Breakthrough fungemia developed in 7 patients using echinocandins, fluconazole, and posaconazole. Liposomal amphotericin B and voriconazole were used for initial treatment. The general mortality rate was 37%. All isolates were resistant to echinocandins. Voriconazole possessed the lowest minimum inhibitory concentration value against all isolates. The survival rate was higher among young patients. Mortality was higher among patients followed up in the intensive care unit. Conclusion: Life-threatening Magnusiomyces spp. can spread among patients with long-term neutropenia under treatment for hematological malignancies. Awareness and prompt initiation of treatment can reduce the risk of mortality in invasive infections caused by Magnusiomyces spp.</p>","PeriodicalId":53592,"journal":{"name":"Eurasian Journal of Medicine","volume":"57 1","pages":"1-6"},"PeriodicalIF":0.9,"publicationDate":"2025-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12102678/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144080708","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigation of Hepatitis B Virus (HBsAg, Anti-HBs) and Anti-Hepatitis C Virus Serology in Erzurum Region: 2015-2023. 2015-2023年埃尔祖鲁姆地区乙型肝炎病毒(HBsAg、Anti-HBs)和丙型肝炎病毒血清检测
IF 0.9 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-04-30 DOI: 10.5152/eurasianjmed.2025.24635
Mahmut Uçar, Ahmet Yılmaz, Demet Çelebi, Özgür Çelebi

Background: Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are among the problems affecting public health worldwide. In this study, we aimed to retrospectively examine the results of patients whose hepatitis B (hepatitis B surface antigen (HBsAg), anti-HBs (Hepatitis B surface antibody) and hepatitis C serology were analyzed by family physicians in the provincial center of Erzurum and to investigate the change in seroprevalence by gender, age groups, and years. Methods: The serology results of individuals whose HBV and anti-HCV serology were analyzed by family physicians in Erzurum between 2015-2023 were evaluated retrospectively. Hepatitis B virus and anti-HCV analyses of the patients were performed in the Public Health Microbiology Laboratory using the chemilu minescence enzyme immunoassay method in accordance with the study procedure of the producing company. These records of the patients were obtained from the laboratory automation system with permission obtained from the Health Directorate. Results: Our study's population consisted of 150 862 people. The study determined that HBsAg, anti-HBs, and anti-HCV seropositivity rates were 1.7%, 58.0%, and 0.02%, respectively. The difference between HBsAg and anti-HBs seropositivity results was statistically significant between individuals born before 1998 and those born after 1998. Conclusion: In our study, it is significant that the HBsAg positivity rate tends to decrease, and anti-HBs sero- positivity has been observed at higher rates in recent years. The rate of anti-HCV seropositivity was found to be lower compared to other studies conducted in our region.

背景:乙型肝炎病毒(HBV)和丙型肝炎病毒(HCV)感染是影响全球公共卫生的问题之一。在这项研究中,我们旨在回顾性检查由埃尔祖鲁姆省中心的家庭医生分析的乙型肝炎(乙型肝炎表面抗原(HBsAg),抗乙型肝炎(乙型肝炎表面抗体)和丙型肝炎血清学患者的结果,并调查血清阳性率在性别,年龄组和年龄方面的变化。方法:回顾性分析2015-2023年埃尔祖鲁姆地区家庭医生对个体进行HBV和抗hcv血清学分析的血清学结果。在公共卫生微生物实验室按照生产公司的研究程序,采用化学发光酶免疫分析法对患者进行乙型肝炎病毒和抗丙型肝炎病毒分析。这些患者的记录是从实验室自动化系统获得的,并获得了卫生部的许可。结果:我们的研究人群包括150862人。研究确定HBsAg、anti-HBs和anti-HCV血清阳性率分别为1.7%、58.0%和0.02%。1998年以前和1998年以后出生的人群HBsAg和anti-HBs血清阳性结果差异有统计学意义。结论:在我们的研究中,近年来HBsAg阳性率呈下降趋势,抗- hbs血清阳性率呈上升趋势。与本地区进行的其他研究相比,发现抗hcv血清阳性率较低。
{"title":"Investigation of Hepatitis B Virus (HBsAg, Anti-HBs) and Anti-Hepatitis C Virus Serology in Erzurum Region: 2015-2023.","authors":"Mahmut Uçar, Ahmet Yılmaz, Demet Çelebi, Özgür Çelebi","doi":"10.5152/eurasianjmed.2025.24635","DOIUrl":"10.5152/eurasianjmed.2025.24635","url":null,"abstract":"<p><p>Background: Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are among the problems affecting public health worldwide. In this study, we aimed to retrospectively examine the results of patients whose hepatitis B (hepatitis B surface antigen (HBsAg), anti-HBs (Hepatitis B surface antibody) and hepatitis C serology were analyzed by family physicians in the provincial center of Erzurum and to investigate the change in seroprevalence by gender, age groups, and years. Methods: The serology results of individuals whose HBV and anti-HCV serology were analyzed by family physicians in Erzurum between 2015-2023 were evaluated retrospectively. Hepatitis B virus and anti-HCV analyses of the patients were performed in the Public Health Microbiology Laboratory using the chemilu minescence enzyme immunoassay method in accordance with the study procedure of the producing company. These records of the patients were obtained from the laboratory automation system with permission obtained from the Health Directorate. Results: Our study's population consisted of 150 862 people. The study determined that HBsAg, anti-HBs, and anti-HCV seropositivity rates were 1.7%, 58.0%, and 0.02%, respectively. The difference between HBsAg and anti-HBs seropositivity results was statistically significant between individuals born before 1998 and those born after 1998. Conclusion: In our study, it is significant that the HBsAg positivity rate tends to decrease, and anti-HBs sero- positivity has been observed at higher rates in recent years. The rate of anti-HCV seropositivity was found to be lower compared to other studies conducted in our region.</p>","PeriodicalId":53592,"journal":{"name":"Eurasian Journal of Medicine","volume":"57 1","pages":"1-5"},"PeriodicalIF":0.9,"publicationDate":"2025-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12102679/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144081664","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of Cribriform Pattern on Progression-Free Survival After Radical Prostatectomy in Gleason Score 8-10 Prostate Cancer. 筛状模式对Gleason评分8-10分前列腺癌根治性前列腺切除术后无进展生存的影响。
IF 0.9 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-04-21 DOI: 10.5152/eurasianjmed.2025.25804
Tyler Walburn, Yetkin Tuaç, Çağdaş Aktan, Okan Argun, Luke W Chen, David D Yang, Shalini Moningi, Jonathan E Leeman, Peter F Orio, Paul L Nguyen, Anthony V D'Amico, Mutlay Sayan

Background: Although extensive research highlights the detrimental effect of cribriform pattern 4 (CP4) on survival in non-high-risk prostate cancer (PC), its prognostic significance in high-risk PC is not well understood. Methods: The individual patient data from the The Cancer Genome Atlas (TCGA) database following radical prostatectomy was retrospectively examined. A predefined statistical analysis was conducted to evaluate the potential association between CP4 and progression-free survival (PFS). Results: Of the 135 patients examined, CP4 was present in 66 (48.9%). Median follow-up was 45.93 months (interquartile range: 22.87, 80.10). Cribriform pattern 4 was associated with a significantly reduced PFS (subdistribution hazard ratio, 1.99; 95% CI, 1.01-3.92; P=.045) following adjustment for covariates. Conclusions: The presence of CP4 in high-risk Gleason 8-10 PC portends worse PFS. Further studies are warranted to fully understand its implications in risk stratification and post-operative management of PC.

背景:尽管大量研究强调了筛状模式4 (CP4)对非高危前列腺癌(PC)患者生存的不利影响,但其在高危前列腺癌(PC)中的预后意义尚不清楚。方法:回顾性分析根治性前列腺切除术后癌症基因组图谱(TCGA)数据库中的个体患者数据。进行了预先定义的统计分析,以评估CP4与无进展生存期(PFS)之间的潜在关联。结果:135例患者中,66例(48.9%)存在CP4。中位随访时间为45.93个月(四分位数间距:22.87,80.10)。筛网型4与PFS显著降低相关(亚分布风险比,1.99;95% ci, 1.01-3.92;P=.045)。结论:高危Gleason 8-10 PC中存在CP4预示着更差的PFS。进一步的研究需要充分了解其在前列腺癌风险分层和术后管理中的意义。
{"title":"Impact of Cribriform Pattern on Progression-Free Survival After Radical Prostatectomy in Gleason Score 8-10 Prostate Cancer.","authors":"Tyler Walburn, Yetkin Tuaç, Çağdaş Aktan, Okan Argun, Luke W Chen, David D Yang, Shalini Moningi, Jonathan E Leeman, Peter F Orio, Paul L Nguyen, Anthony V D'Amico, Mutlay Sayan","doi":"10.5152/eurasianjmed.2025.25804","DOIUrl":"10.5152/eurasianjmed.2025.25804","url":null,"abstract":"<p><p>Background: Although extensive research highlights the detrimental effect of cribriform pattern 4 (CP4) on survival in non-high-risk prostate cancer (PC), its prognostic significance in high-risk PC is not well understood. Methods: The individual patient data from the The Cancer Genome Atlas (TCGA) database following radical prostatectomy was retrospectively examined. A predefined statistical analysis was conducted to evaluate the potential association between CP4 and progression-free survival (PFS). Results: Of the 135 patients examined, CP4 was present in 66 (48.9%). Median follow-up was 45.93 months (interquartile range: 22.87, 80.10). Cribriform pattern 4 was associated with a significantly reduced PFS (subdistribution hazard ratio, 1.99; 95% CI, 1.01-3.92; P=.045) following adjustment for covariates. Conclusions: The presence of CP4 in high-risk Gleason 8-10 PC portends worse PFS. Further studies are warranted to fully understand its implications in risk stratification and post-operative management of PC.</p>","PeriodicalId":53592,"journal":{"name":"Eurasian Journal of Medicine","volume":"57 1","pages":"1-5"},"PeriodicalIF":0.9,"publicationDate":"2025-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12038371/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144081662","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New Gene Targets for Diagnosis and Therapy of Diabetic Retinopathy. 糖尿病视网膜病变诊断和治疗的新基因靶点。
IF 0.9 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-04-19 DOI: 10.5152/eurasianjmed.2025.24559
Emine Çinici, Mehmet Enes Arslan, Özge Çağlar Yıldırım, Nilay Dilekmen, Bahadır Utlu, Özkan Çinici, Zehra Sağlam, Hasan Türkez

Objective: Diabetic retinopathy (DR), considered one of the most common microvascular complications associated with diabetes mellitus (DM), involves both neuronal and vascular dysfunctions in the retina. Neuronal damage and vision loss occur progressively in patients with DR. A number of genetic targets have been identified for DR and gene-related treatments as well as early diagnostic techniques have been developed. Despite some medical advances, DR remains a devastating complication of diabetes. This study aimed to identify new gene targets that can be used for the prognosis and treatment of DR.. Materials and Methods: Eight candidate genes were analyzed using Synergy Brands Green (SYBR-green)- based real-time polymerase chain reaction in peripheral blood mononuclear cells (PBMCs) from 45 individuals: DR patients (n=15), DM patients without DR (n=15), and healthy controls (n=15). STRING v11 was used for protein-protein interaction analysis. Gene expression differences were evaluated using ANOVA, with significance set at P < .05. Results: HIF1A and VEGFA were significantly upregulated in both DR and DM groups compared to controls (HIF1A: fold change 5.28; VEGFA: fold change 5.20 for DR group). SERPING1 was specifically upregulated in DR patients (fold change 3.42). CX3CR1 and BDNF were downregulated in both DR and DM groups (CX3CR1: fold change 8.32; BDNF: fold change 3.21), while IGFBP3 was significantly downregulated only in DR patients (fold change 6.5). STRING analysis revealed strong interactions between SERPING1 and complement pathway components, while IGFBP3 was linked to insulin-like growth factor signaling. Conclusion: In light of these findings, we observed that SERPING1 and IGFBP3 genes might be proposed as targets for early diagnosis and treatment for DR.

目的:糖尿病视网膜病变(DR)被认为是糖尿病(DM)最常见的微血管并发症之一,涉及视网膜的神经和血管功能障碍。神经损伤和视力丧失在DR患者中逐渐发生,已经确定了许多DR的遗传靶点,基因相关治疗以及早期诊断技术已经开发出来。尽管医学上取得了一些进步,DR仍然是糖尿病的一种毁灭性并发症。本研究旨在发现可用于DR预后和治疗的新基因靶点。材料和方法:采用Synergy Brands Green (SYBR-green)实时聚合酶链反应对45例患者外周血单个核细胞(PBMCs)中的8个候选基因进行分析:DR患者(n=15)、无DR的DM患者(n=15)和健康对照(n=15)。使用STRING v11进行蛋白相互作用分析。基因表达差异采用方差分析评估,P < 0.05为显著性。结果:与对照组相比,DR和DM组中HIF1A和VEGFA均显著上调(HIF1A: fold change 5.28;VEGFA:折叠变化5.20 (DR组)。SERPING1在DR患者中特异性上调(翻倍变化3.42)。DR和DM组CX3CR1和BDNF均下调(CX3CR1: fold change 8.32;BDNF:折叠变化3.21),而IGFBP3仅在DR患者中显著下调(折叠变化6.5)。STRING分析显示SERPING1与补体通路组分之间存在强相互作用,而IGFBP3与胰岛素样生长因子信号传导有关。结论:基于这些发现,我们认为SERPING1和IGFBP3基因可能是DR早期诊断和治疗的靶点。
{"title":"New Gene Targets for Diagnosis and Therapy of Diabetic Retinopathy.","authors":"Emine Çinici, Mehmet Enes Arslan, Özge Çağlar Yıldırım, Nilay Dilekmen, Bahadır Utlu, Özkan Çinici, Zehra Sağlam, Hasan Türkez","doi":"10.5152/eurasianjmed.2025.24559","DOIUrl":"10.5152/eurasianjmed.2025.24559","url":null,"abstract":"<p><p>Objective: Diabetic retinopathy (DR), considered one of the most common microvascular complications associated with diabetes mellitus (DM), involves both neuronal and vascular dysfunctions in the retina. Neuronal damage and vision loss occur progressively in patients with DR. A number of genetic targets have been identified for DR and gene-related treatments as well as early diagnostic techniques have been developed. Despite some medical advances, DR remains a devastating complication of diabetes. This study aimed to identify new gene targets that can be used for the prognosis and treatment of DR.. Materials and Methods: Eight candidate genes were analyzed using Synergy Brands Green (SYBR-green)- based real-time polymerase chain reaction in peripheral blood mononuclear cells (PBMCs) from 45 individuals: DR patients (n=15), DM patients without DR (n=15), and healthy controls (n=15). STRING v11 was used for protein-protein interaction analysis. Gene expression differences were evaluated using ANOVA, with significance set at P < .05. Results: HIF1A and VEGFA were significantly upregulated in both DR and DM groups compared to controls (HIF1A: fold change 5.28; VEGFA: fold change 5.20 for DR group). SERPING1 was specifically upregulated in DR patients (fold change 3.42). CX3CR1 and BDNF were downregulated in both DR and DM groups (CX3CR1: fold change 8.32; BDNF: fold change 3.21), while IGFBP3 was significantly downregulated only in DR patients (fold change 6.5). STRING analysis revealed strong interactions between SERPING1 and complement pathway components, while IGFBP3 was linked to insulin-like growth factor signaling. Conclusion: In light of these findings, we observed that SERPING1 and IGFBP3 genes might be proposed as targets for early diagnosis and treatment for DR.</p>","PeriodicalId":53592,"journal":{"name":"Eurasian Journal of Medicine","volume":"57 1","pages":"1-6"},"PeriodicalIF":0.9,"publicationDate":"2025-04-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12036348/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144081706","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnostic Performance of Sarcopenia Screening Tests in Chronic Lung Disease Patients. 慢性肺病患者肌少症筛查试验的诊断价值
IF 0.9 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-04-17 DOI: 10.5152/eurasianjmed.2025.25806
Aslı Görek Dilektaşlı, Demet Kerimoğlu, Ayten Odabaş, Abdurrahman Doğan, Arzu Özpehlivan, Nilüfer Aylin Acet Öztürk, Özge Aydın Güçlü, Ezgi Demirdöğen, Funda Coşkun, Ahmet Ursavaş, Esra Uzaslan, Mehmet Karadağ

Objective: Sarcopenia, the gradual decline in skeletal muscle mass (SMM), strength, and functionality, has negative health consequences such as premature death and disability. It is prevalent in chronic lung disease (CLD). Timely recognition of sarcopenia is required for focused therapy. This study sought to analyze the rate of sarcopenia in patients with CLD and to assess the diagnostic accuracy of the sarcopenia screening tests: the SARC-F, SARC-CalF, and Ishii tests. Materials and Methods: This study comprised individuals diagnosed with CLD and referred for pulmonary rehabilitation. Sarcopenia was evaluated based on the European Working Group on Sarcopenia in Older People criteria (EWGSOP and EWGSOP2), utilizing handgrip strength, SMM index, and gait speed. The diagnostic accuracy of screening tests (SARC-F, SARC-CalF, and Ishii) was assessed by sensitivity, specificity, and the area under the curve (AUC) in the Receiver Ooperating Ccharacteristics. Results: A total of 227 patients, with a mean age of 59.00 ± 13.98 years, of whom 50.7% had chronic obstructive pulmonary disease (COPD), were included. The rate of probable sarcopenia was 41.2%, confirmed sarcopenia 2.5%, and severe sarcopenia 0.5%. The Ishii test exhibited the highest sensitivity (71.59%) and specificity (90.48%) for probable sarcopenia (AUC: 0.810); it also showed 100% sensitivity and substantial specificity (78.57%, AUC: 0.893) for confirmed sarcopenia. Conclusion: Sarcopenia is highly prevalent in CLD patients, underscoring the need for routine screening. Among the screening tools, the Ishii test exhibited the highest diagnostic accuracy, making it a valuable tool for early detection. Routine assessment and targeted interventions for sarcopenia could improve functional outcomes in CLD patients.

目的:骨骼肌减少症,骨骼肌质量(SMM)、力量和功能的逐渐下降,对健康有负面影响,如过早死亡和残疾。它在慢性肺病(CLD)中很常见。及时识别肌肉减少症需要集中治疗。本研究旨在分析CLD患者肌少症的发生率,并评估肌少症筛查试验(SARC-F、SARC-CalF和Ishii试验)的诊断准确性。材料和方法:本研究纳入了诊断为CLD并转诊进行肺部康复治疗的个体。根据欧洲老年人肌肉减少症工作组标准(EWGSOP和EWGSOP2),利用握力、SMM指数和步态速度对肌肉减少症进行评估。筛选试验(SARC-F、SARC-CalF和Ishii)的诊断准确性通过敏感性、特异性和受者操作c特征的曲线下面积(AUC)来评估。结果:共纳入227例患者,平均年龄59.00±13.98岁,其中50.7%患有慢性阻塞性肺疾病(COPD)。可能的肌肉减少率为41.2%,确诊的为2.5%,严重的为0.5%。Ishii试验对可能的肌肉减少症的敏感性(71.59%)和特异性(90.48%)最高(AUC: 0.810);对确诊的肌少症也显示出100%的敏感性和可观的特异性(78.57%,AUC: 0.893)。结论:骨骼肌减少症在CLD患者中非常普遍,强调常规筛查的必要性。在筛查工具中,石井试验显示出最高的诊断准确性,使其成为早期检测的宝贵工具。对肌肉减少症的常规评估和有针对性的干预可以改善CLD患者的功能结局。
{"title":"Diagnostic Performance of Sarcopenia Screening Tests in Chronic Lung Disease Patients.","authors":"Aslı Görek Dilektaşlı, Demet Kerimoğlu, Ayten Odabaş, Abdurrahman Doğan, Arzu Özpehlivan, Nilüfer Aylin Acet Öztürk, Özge Aydın Güçlü, Ezgi Demirdöğen, Funda Coşkun, Ahmet Ursavaş, Esra Uzaslan, Mehmet Karadağ","doi":"10.5152/eurasianjmed.2025.25806","DOIUrl":"10.5152/eurasianjmed.2025.25806","url":null,"abstract":"<p><p>Objective: Sarcopenia, the gradual decline in skeletal muscle mass (SMM), strength, and functionality, has negative health consequences such as premature death and disability. It is prevalent in chronic lung disease (CLD). Timely recognition of sarcopenia is required for focused therapy. This study sought to analyze the rate of sarcopenia in patients with CLD and to assess the diagnostic accuracy of the sarcopenia screening tests: the SARC-F, SARC-CalF, and Ishii tests. Materials and Methods: This study comprised individuals diagnosed with CLD and referred for pulmonary rehabilitation. Sarcopenia was evaluated based on the European Working Group on Sarcopenia in Older People criteria (EWGSOP and EWGSOP2), utilizing handgrip strength, SMM index, and gait speed. The diagnostic accuracy of screening tests (SARC-F, SARC-CalF, and Ishii) was assessed by sensitivity, specificity, and the area under the curve (AUC) in the Receiver Ooperating Ccharacteristics. Results: A total of 227 patients, with a mean age of 59.00 ± 13.98 years, of whom 50.7% had chronic obstructive pulmonary disease (COPD), were included. The rate of probable sarcopenia was 41.2%, confirmed sarcopenia 2.5%, and severe sarcopenia 0.5%. The Ishii test exhibited the highest sensitivity (71.59%) and specificity (90.48%) for probable sarcopenia (AUC: 0.810); it also showed 100% sensitivity and substantial specificity (78.57%, AUC: 0.893) for confirmed sarcopenia. Conclusion: Sarcopenia is highly prevalent in CLD patients, underscoring the need for routine screening. Among the screening tools, the Ishii test exhibited the highest diagnostic accuracy, making it a valuable tool for early detection. Routine assessment and targeted interventions for sarcopenia could improve functional outcomes in CLD patients.</p>","PeriodicalId":53592,"journal":{"name":"Eurasian Journal of Medicine","volume":"57 1","pages":"1-7"},"PeriodicalIF":0.9,"publicationDate":"2025-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12036431/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144081624","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effectiveness of 4-Factor Prothrombin Complex Concentrate with and without Vitamin K in Managing Warfarin-Associated Major Bleeding. 含或不含维生素K的4因子凝血酶原复合浓缩物在治疗华法林相关性大出血中的有效性。
IF 0.9 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-04-14 DOI: 10.5152/eurasianjmed.2025.25710
Şeyma Arzu Temür, Mustafa Selçuk Ayar, Yiğit Kurnaz, Fatih Çalışkan

Background: Major bleeding is a common and severe complication associated with vitamin K antagonist use. Rapid reversal of anticoagulation is crucial in cases of acute bleeding. Prothrombin complex concentrates (PCC) have emerged as an effective option. This study examines the efficacy of 4-factor PCC (4F-PCC) alone and in combination with vitamin K for International Normalized Ratio (INR) control in patients with life-threatening bleeding due to warfarin. Methods: This retrospective cross-sectional study included 50 patients who presented with bleeding and coagulopathy to the Ondokuz Mayıs University Health Practice and Research Center Adult Emergency Department between January 1, 2022, and January 1, 2023. Patients were divided into 2 groups based on vitamin K administration within 24 hours: group 1 received only 4F-PCC, while group 2 received both 4F-PCC and vitamin K. Results: The median age of patients was 72 years, 56% were male. The most common indication for warfarin use was heart valve disease (54%). Gastrointestinal hemorrhage was the leading cause of bleeding (44%). Mortality was 26%, with all deaths occurring within 72 hours of admission. Group 2 had significantly lower INR levels at 24th-hour than group 1 (P=.048). No significant differences were found in INR levels between the 1st and 24th hours within either group (P > .05). Conclusion: The study demonstrates that the combination of 4F-PCC and vitamin K is more effective in controlling INR than 4F-PCC alone, though it does not significantly impact rebound INR increases. Further prospective, multicenter studies are needed to confirm these findings and explore long-term outcomes.

背景:大出血是与使用维生素K拮抗剂相关的常见且严重的并发症。在急性出血的情况下,迅速逆转抗凝是至关重要的。凝血酶原复合物浓缩物(PCC)已成为一种有效的选择。本研究探讨了4因子PCC (4F-PCC)单独和联合维生素K对华法林所致危及生命的出血患者的国际标准化比率(INR)控制的疗效。方法:这项回顾性横断面研究纳入了2022年1月1日至2023年1月1日期间在Ondokuz Mayıs大学卫生实践与研究中心成人急诊科就诊的50例出血和凝血功能障碍患者。根据24小时内给予维生素K的情况将患者分为两组:1组仅给予4F-PCC, 2组同时给予4F-PCC和维生素K。结果:患者年龄中位数为72岁,男性占56%。华法林最常见的适应症是心脏瓣膜疾病(54%)。胃肠道出血是出血的主要原因(44%)。死亡率为26%,所有死亡均发生在入院后72小时内。2组患者24小时INR水平显著低于1组(P= 0.048)。两组患者第1小时和第24小时INR水平均无显著差异(P < 0.05)。结论:本研究表明,4F-PCC联合维生素K比单独使用4F-PCC更有效地控制INR,但对反弹INR的增加没有显著影响。需要进一步的前瞻性、多中心研究来证实这些发现并探索长期结果。
{"title":"Effectiveness of 4-Factor Prothrombin Complex Concentrate with and without Vitamin K in Managing Warfarin-Associated Major Bleeding.","authors":"Şeyma Arzu Temür, Mustafa Selçuk Ayar, Yiğit Kurnaz, Fatih Çalışkan","doi":"10.5152/eurasianjmed.2025.25710","DOIUrl":"10.5152/eurasianjmed.2025.25710","url":null,"abstract":"<p><p>Background: Major bleeding is a common and severe complication associated with vitamin K antagonist use. Rapid reversal of anticoagulation is crucial in cases of acute bleeding. Prothrombin complex concentrates (PCC) have emerged as an effective option. This study examines the efficacy of 4-factor PCC (4F-PCC) alone and in combination with vitamin K for International Normalized Ratio (INR) control in patients with life-threatening bleeding due to warfarin. Methods: This retrospective cross-sectional study included 50 patients who presented with bleeding and coagulopathy to the Ondokuz Mayıs University Health Practice and Research Center Adult Emergency Department between January 1, 2022, and January 1, 2023. Patients were divided into 2 groups based on vitamin K administration within 24 hours: group 1 received only 4F-PCC, while group 2 received both 4F-PCC and vitamin K. Results: The median age of patients was 72 years, 56% were male. The most common indication for warfarin use was heart valve disease (54%). Gastrointestinal hemorrhage was the leading cause of bleeding (44%). Mortality was 26%, with all deaths occurring within 72 hours of admission. Group 2 had significantly lower INR levels at 24th-hour than group 1 (P=.048). No significant differences were found in INR levels between the 1st and 24th hours within either group (P > .05). Conclusion: The study demonstrates that the combination of 4F-PCC and vitamin K is more effective in controlling INR than 4F-PCC alone, though it does not significantly impact rebound INR increases. Further prospective, multicenter studies are needed to confirm these findings and explore long-term outcomes.</p>","PeriodicalId":53592,"journal":{"name":"Eurasian Journal of Medicine","volume":"57 1","pages":"1-4"},"PeriodicalIF":0.9,"publicationDate":"2025-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12036368/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144081692","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Immediate Effects of Different Types of Tea Consumption on Ocular Biometric and Specular Microscopic Parameters in Healthy Subjects. 不同类型的茶消费对健康受试者眼部生物特征和镜面显微参数的直接影响。
IF 0.9 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-04-07 DOI: 10.5152/eurasianjmed.2025.24589
Feyzahan Uzun, Emre Aydın, Hasan Akgöz, Mehmet Gökhan Aslan, Hüseyin Fındık

Background: Tea ranks among the most popular beverages globally. In this study, we assessed the short-term changes in ocular biometric and specular microscopic parameters in healthy subjects following the consumption of different types of tea. Methods: A total of 144 subjects were randomly assigned to 3 groups (black, green, and white tea groups) in this study. Ocular parameters, including axial length (AL), aqueous depth (AD), lens thickness (LT), and central corneal thickness (CCT), were measured using optic biometry. Endothelial cell density (ECD), coefficient of variation (CV), number of hexagonal cells (A6A), and average cell area (AVG) were evaluated using non-contact specular microscopy before, as well as 1 hour and 4 hours after, consuming a cup of tea (containing 60 mg of caffeine per 100 mL). Results: The average age of the subjects was 32.9 ± 5.9 years. A significant increase in AD values was observed specifically at the 1st hour following the consumption of black, green, or white tea in healthy subjects. Additionally, black and white tea significantly reduced LT in the 1st hour of the study. The differences in AL and CCT values, as well as in specular microscopy parameters, were not significant among all participants after consuming different types of tea. Conclusion: Black, green, and white tea induce a significant increase in AD, particularly observed 1 hour after oral intake. Furthermore, a reduction in LT parameters was observed in the black and white tea groups, respectively.

背景:茶是全球最受欢迎的饮料之一。在这项研究中,我们评估了健康受试者在饮用不同类型的茶后眼部生物特征和镜面显微参数的短期变化。方法:将144名受试者随机分为红茶组、绿茶组和白茶组。使用光学生物测量法测量眼参数,包括眼轴长(AL)、水深(AD)、晶状体厚度(LT)和角膜中央厚度(CCT)。使用非接触式镜面显微镜,分别在饮用一杯茶(每100 mL含有60 mg咖啡因)前、后1小时和4小时,评估内皮细胞密度(ECD)、变异系数(CV)、六边形细胞数(A6A)和平均细胞面积(AVG)。结果:患者平均年龄32.9±5.9岁。在健康受试者中,特别是在饮用红茶、绿茶或白茶后的第1小时,AD值显著增加。此外,红茶和白茶在研究的第一个小时内显着降低了LT。在饮用不同类型的茶后,所有参与者的AL值和CCT值以及镜面显微镜参数的差异均不显著。结论:黑茶、绿茶和白茶可显著增加AD,尤其是在口服1小时后。此外,黑茶组和白茶组分别观察到LT参数的降低。
{"title":"The Immediate Effects of Different Types of Tea Consumption on Ocular Biometric and Specular Microscopic Parameters in Healthy Subjects.","authors":"Feyzahan Uzun, Emre Aydın, Hasan Akgöz, Mehmet Gökhan Aslan, Hüseyin Fındık","doi":"10.5152/eurasianjmed.2025.24589","DOIUrl":"10.5152/eurasianjmed.2025.24589","url":null,"abstract":"<p><p>Background: Tea ranks among the most popular beverages globally. In this study, we assessed the short-term changes in ocular biometric and specular microscopic parameters in healthy subjects following the consumption of different types of tea. Methods: A total of 144 subjects were randomly assigned to 3 groups (black, green, and white tea groups) in this study. Ocular parameters, including axial length (AL), aqueous depth (AD), lens thickness (LT), and central corneal thickness (CCT), were measured using optic biometry. Endothelial cell density (ECD), coefficient of variation (CV), number of hexagonal cells (A6A), and average cell area (AVG) were evaluated using non-contact specular microscopy before, as well as 1 hour and 4 hours after, consuming a cup of tea (containing 60 mg of caffeine per 100 mL). Results: The average age of the subjects was 32.9 ± 5.9 years. A significant increase in AD values was observed specifically at the 1st hour following the consumption of black, green, or white tea in healthy subjects. Additionally, black and white tea significantly reduced LT in the 1st hour of the study. The differences in AL and CCT values, as well as in specular microscopy parameters, were not significant among all participants after consuming different types of tea. Conclusion: Black, green, and white tea induce a significant increase in AD, particularly observed 1 hour after oral intake. Furthermore, a reduction in LT parameters was observed in the black and white tea groups, respectively.</p>","PeriodicalId":53592,"journal":{"name":"Eurasian Journal of Medicine","volume":"57 1","pages":"1-5"},"PeriodicalIF":0.9,"publicationDate":"2025-04-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12036367/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144081748","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unraveling the Enigma: Exploring the Periphery's Influence in Alzheimer's Pathophysiology-Cause or Consequence? 解开谜团:探索外围区对阿尔茨海默病病理生理的影响——原因还是结果?
IF 0.9 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-04-04 DOI: 10.5152/eurasianjmed.2025.24592
Gamze Sönmez, Yiğit Yazarkan, Özlem Erden Aki, Ebru Bodur

Alzheimer's disease (AD) remains a formidable challenge, impacting individuals, families, caregivers, and soci- ety. Despite being identified over a century ago, effective drug treatments for AD remain elusive, with numerous clinical trials failing to produce meaningful results. The pathological hallmarks of AD, including the accumulation of beta-amyloid plaques and tau protein tangles, are well-established contributors to cogni- tive decline. However, recent research has raised questions about the efficacy of therapies targeting these abnormalities. Emerging evidence suggests that AD should not be viewed purely as a brain-centered disease but as a systemic condition involving complex interactions between the brain and peripheral organs. While the mechanisms linking peripheral processes and AD pathology remain unclear, studies indicate that these systems may contribute to or be affected by the disease. Recognizing AD as a heterogeneous disorder with systemic implications opens new opportunities for therapeutic innovation. Multimodal therapies targeting both central and peripheral aspects of AD pathology-such as amyloid-beta deposition, neuroinflammation, and systemic dysfunction-hold promise for slowing disease progression. This review aims to critically assess the current understanding of AD pathology, with a particular focus on the peripheral system's involvement and its interplay with the brain. Additionally, it will explore novel therapeutic strategies and emphasize the importance of interdisciplinary collaboration to advance our knowledge and develop effective treatments.

阿尔茨海默病(AD)仍然是一个巨大的挑战,影响着个人、家庭、照顾者和社会。尽管早在一个多世纪前就被发现,但有效的阿尔茨海默病药物治疗仍然难以捉摸,许多临床试验未能产生有意义的结果。阿尔茨海默病的病理特征,包括β -淀粉样斑块和tau蛋白缠结的积累,是公认的导致认知能力下降的因素。然而,最近的研究对针对这些异常的治疗效果提出了质疑。新出现的证据表明,阿尔茨海默病不应纯粹被视为一种以大脑为中心的疾病,而应被视为一种涉及大脑和周围器官之间复杂相互作用的全身性疾病。虽然外周过程和AD病理之间的联系机制尚不清楚,但研究表明,这些系统可能促成或受该疾病的影响。认识到阿尔茨海默病是一种具有系统性影响的异质性疾病,为治疗创新提供了新的机会。针对阿尔茨海默病中枢性和外周性病变(如淀粉样蛋白沉积、神经炎症和全身性功能障碍)的多模式治疗有望减缓疾病进展。这篇综述旨在批判性地评估当前对阿尔茨海默病病理的理解,特别关注外周系统的参与及其与大脑的相互作用。此外,它将探索新的治疗策略,并强调跨学科合作的重要性,以提高我们的知识和开发有效的治疗方法。
{"title":"Unraveling the Enigma: Exploring the Periphery's Influence in Alzheimer's Pathophysiology-Cause or Consequence?","authors":"Gamze Sönmez, Yiğit Yazarkan, Özlem Erden Aki, Ebru Bodur","doi":"10.5152/eurasianjmed.2025.24592","DOIUrl":"10.5152/eurasianjmed.2025.24592","url":null,"abstract":"<p><p>Alzheimer's disease (AD) remains a formidable challenge, impacting individuals, families, caregivers, and soci- ety. Despite being identified over a century ago, effective drug treatments for AD remain elusive, with numerous clinical trials failing to produce meaningful results. The pathological hallmarks of AD, including the accumulation of beta-amyloid plaques and tau protein tangles, are well-established contributors to cogni- tive decline. However, recent research has raised questions about the efficacy of therapies targeting these abnormalities. Emerging evidence suggests that AD should not be viewed purely as a brain-centered disease but as a systemic condition involving complex interactions between the brain and peripheral organs. While the mechanisms linking peripheral processes and AD pathology remain unclear, studies indicate that these systems may contribute to or be affected by the disease. Recognizing AD as a heterogeneous disorder with systemic implications opens new opportunities for therapeutic innovation. Multimodal therapies targeting both central and peripheral aspects of AD pathology-such as amyloid-beta deposition, neuroinflammation, and systemic dysfunction-hold promise for slowing disease progression. This review aims to critically assess the current understanding of AD pathology, with a particular focus on the peripheral system's involvement and its interplay with the brain. Additionally, it will explore novel therapeutic strategies and emphasize the importance of interdisciplinary collaboration to advance our knowledge and develop effective treatments.</p>","PeriodicalId":53592,"journal":{"name":"Eurasian Journal of Medicine","volume":"57 1","pages":"1-8"},"PeriodicalIF":0.9,"publicationDate":"2025-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12036350/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144081783","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relationship Between Quality Perception and Patient Expectations with Patient Demographic Structure in Health Care Institutions and Organizations: Atatürk University Faculty of Dentistry Example. 卫生保健机构和组织中质量感知和患者期望与患者人口结构的关系:atatrk大学牙科学院为例。
IF 0.9 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-03-26 DOI: 10.5152/eurasianjmed.2025.23164
Doğan Durna, Özkan Demirtaş, Nurhan Bayındır Durna, Vecihi Yiğit

Background: To reveal whether the quality perceptions service expectations of patients and their relatives who come to health institutions for examination and treatment differ according to their demographic structures. Methods: The data collection tool used was the Patient Satisfaction Survey. The sample of the study consisted of 428 patients aged 21 and over 21 years who applied to Atatürk University Faculty of Dentistry for dental examinations between April 1, 2022 and July 31, 2022. The descriptive scanning method, one of the quantitative research methods, was used in the study. Survey analyzes were evaluated using scientific statistical analysis techniques described in the literature, and IBM Statistical Package for the Social Sciences (IBM SPSS Corp.; Armonk, NY, USA) Statistics 20 software was used. Results: Since the normal distribution condition was not met in normality tests, nonparametric tests were performed. Nonparametric tests revealed that patients' perceptions of quality and expectations did not differ according to gender, education, or marital status. On the other hand, patients' perceptions of quality and expectations differed according to age, profession, and monthly income. Conclusion: As a result of the statistical evaluation of the survey results, it was revealed that the quality perception and patient expectations in health institutions and organizations vary according to the demographic structures of the patients such as gender, age, education level, and monthly income.

背景:了解到医疗机构就诊的患者及其亲属的质量感知和服务期望是否因人口结构的不同而存在差异。方法:资料收集工具为患者满意度调查。该研究的样本包括428名年龄在21岁及21岁以上的患者,他们在2022年4月1日至2022年7月31日期间申请到atatrk大学牙科学院进行牙科检查。本研究采用定量研究方法之一的描述扫描法。使用文献中描述的科学统计分析技术评估调查分析,以及IBM社会科学统计软件包(IBM SPSS Corp.;Armonk, NY, USA)使用Statistics 20软件。结果:由于正态性检验不符合正态分布条件,所以采用非参数检验。非参数测试显示,患者对质量的感知和期望并没有因性别、教育程度或婚姻状况而异。另一方面,患者对质量的感知和期望因年龄、职业和月收入而异。结论:对调查结果进行统计评价,发现卫生机构和组织的质量感知和患者期望因患者性别、年龄、文化程度、月收入等人口结构的不同而存在差异。
{"title":"Relationship Between Quality Perception and Patient Expectations with Patient Demographic Structure in Health Care Institutions and Organizations: Atatürk University Faculty of Dentistry Example.","authors":"Doğan Durna, Özkan Demirtaş, Nurhan Bayındır Durna, Vecihi Yiğit","doi":"10.5152/eurasianjmed.2025.23164","DOIUrl":"10.5152/eurasianjmed.2025.23164","url":null,"abstract":"<p><p>Background: To reveal whether the quality perceptions service expectations of patients and their relatives who come to health institutions for examination and treatment differ according to their demographic structures. Methods: The data collection tool used was the Patient Satisfaction Survey. The sample of the study consisted of 428 patients aged 21 and over 21 years who applied to Atatürk University Faculty of Dentistry for dental examinations between April 1, 2022 and July 31, 2022. The descriptive scanning method, one of the quantitative research methods, was used in the study. Survey analyzes were evaluated using scientific statistical analysis techniques described in the literature, and IBM Statistical Package for the Social Sciences (IBM SPSS Corp.; Armonk, NY, USA) Statistics 20 software was used. Results: Since the normal distribution condition was not met in normality tests, nonparametric tests were performed. Nonparametric tests revealed that patients' perceptions of quality and expectations did not differ according to gender, education, or marital status. On the other hand, patients' perceptions of quality and expectations differed according to age, profession, and monthly income. Conclusion: As a result of the statistical evaluation of the survey results, it was revealed that the quality perception and patient expectations in health institutions and organizations vary according to the demographic structures of the patients such as gender, age, education level, and monthly income.</p>","PeriodicalId":53592,"journal":{"name":"Eurasian Journal of Medicine","volume":"57 1","pages":"1-8"},"PeriodicalIF":0.9,"publicationDate":"2025-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12036366/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144081730","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Eurasian Journal of Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1